Given its protective effects in animal models of T2DM and AD [17], and based on its pharmacological actions on neurons, we hypothesize that geniposide downregulates mTOR activity to attenuate symptoms of AD. The gene discussed is MTOR; the disease is type 2 diabetes mellitus.